Table 1.
Baseline Characteristics of Participants by Arm of Study
| Combined (N = 87) | SQG (N = 45) | QG/TCE (N = 42) | |||
|---|---|---|---|---|---|
| Variable | |||||
| Mean(SD) | Mean(SD) | Mean(SD) | t (df) | p- valuea | |
| Age | 58.8 (8.94) | 59.8 (8.93) | 57.7 (8.94) | 1.06 (84) | 0.292 |
| Body Mass Index | 26.8 (4.49) | 26.6 (3.62) | 27.1 (5.33) | −0.43 (82) | 0.665 |
| Metabolic Equivalent of Task (METs) hrs./week | 11.7 (11.40) | 10.2 (10.58) | 13.3 (12.16) | −1.29 (84) | 0.201 |
| n (%) | n (%) | n (%) | p- valueb | ||
| Estrogen Suppressive Therapy | 60 (68.97) | 30 (66.67) | 30 (71.43) | 0.639 | |
| Cancer Stage | |||||
| Stage 1 | 34 (39.08) | 20 (44.44) | 14 (33.33) | 0.722 | |
| Stage 2 | 40 (45.98) | 22 (48.89) | 18 (42.86) | ||
| Stage 3 | 3 ( 3.45) | 1 ( 2.22) | 2 ( 4.76) | ||
| Ethnicity | |||||
| Latino | 2 ( 2.30) | 1 ( 2.22) | 1 ( 2.38) | 1.000 | |
| Non Latino | 75 (86.21) | 40 (88.89) | 35 (83.33) | ||
| Race | |||||
| White | 79 (90.80) | 42 (93.33) | 37 (88.10) | 1.000 | |
| Other | 5 ( 5.75) | 3 ( 6.67) | 2 ( 4.76) | ||
| Household Income | |||||
| < $ 34,999 | 12 (13.79) | 10 (22.22) | 2 ( 4.76) | 0.121 | |
| $ 35,000 to $49,999 | 11 (12.64) | 8 (17.78) | 3 ( 7.14) | ||
| $ 50,000 to $74,999 | 14 (16.09) | 6 (13.33) | 8 (19.05) | ||
| $ 75,000 to $99,999 | 11 (12.64) | 5 (11.11) | 6 (14.29) | ||
| > $100,000 | 18 (20.69) | 8 (17.78) | 10 (23.81) | ||
| Highest Grade of Education | |||||
| High School or Less | 13 (14.94) | 7 (15.56) | 6 (14.29) | 0.746 | |
| Some College | 51 (58.62) | 25 (55.56) | 26 (61.90) | ||
| Post-graduate | 20 (22.99) | 12 (26.67) | 8 (19.05) |
a
p-value from two sample independent t test
b
p-value from Fisher’s Exact Test